NCT06147999 · First Institute of All Medicines
Impact of a Biophoton Therapy on Patients With Brain Disorders
(Alzheimer)
What this study is about
Previous clinical studies revealed that the newly developed biophoton therapy has been safe and effective in treating patients with Alzheimer's disease, dementia, stroke, traumatic brain injury, or Parkinson's disease.
View original scientific description
Previous clinical studies revealed that the newly developed biophoton therapy has been safe and effective in treating patients with Alzheimer's disease, dementia, stroke, traumatic brain injury, or Parkinson's disease. The current study is to confirm the previous clinical observation by conducting as a randomized, triple-blinded, placebo-controlled prospective intervention clinical research. About 80 patients with brain disorder (Alzheimer's disease, dementia, stroke, traumatic brain injury, Parkinson's disease) will participate in the intervention clinical study at the Tesla MedBed Center located in Butler, PA.
Interventions
DEVICE
Biophotonizer - a Biophoton Generator
A biophotonizer is a device producing strong biophoton field. These biophotons help the human body to gain self-healing capacity to heal many disorders, including brain disorders.
Primary outcome measures
Overall Life Quality impacted by Biophoton Therapy
Time frame: 0-2 weeks, 0-4 weeks after starting the study treatment.
Short Form Health Survey (SF-36) will be used to assess life quality: scored from 0 (worst health) to 100 (best heath).
Cognitive Capacity impacted by Biophoton Therapy
Time frame: 0-2 weeks, 0-4 weeks after starting the study treatment.
Montreal Cognitive Assessment (MOCA), Score below 10, severe cognition damage; 26-30, normal cognition.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Must meet conditions for approval.
- Must be 18-years or older and stay in a hotel.
- Must have a caregiver willing to support the participant's full involvement in the study. • The caregiver can assist in completing all study surveys.
- Can provide informed consent or can be assisted by caregiver.
- Can provide a clinical diagnosis of a brain disorder.
- Can complete all study procedures during the study.
- Must be fluent in English (or the Caregiver can fully translate).
- Women of childbearing age must provide results of a pregnancy test in order to participate.
Exclusion criteria
- Any untreated mental illnesses, that would affect study participation. This will be judged by the caregiver, or by the clinical study medical expert.
- Someone that relies on a ventilator.
- Someone who has a deep brain stimulator, pacemaker, or any implanted electronic devices.
- Co-morbid conditions that would interfere with study activities or response to treatment, which may include severe chronic pulmonary disease, history of uncontrolled seizures, acute or chronic infectious illness, severe diabetes, kidney failure, or any end-of-life prognosis.
- Is participating in another investigational drug or device trial.
- Has an active infectious disease, such as COVID-19.
- Pregnant women.
Where
- Butler, Pennsylvania
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Aug 8, 2025 · Source of record for eligibility and locations